Xanadu Quantum Technologies Limited (TSX: XNDU) and Mitsubishi Chemical have secured national innovation program support from Canada and Japan to advance their quantum semiconductor collaboration. The funding enables the next phase of their partnership focused on extreme ultraviolet (EUV) lithography simulations.

The collaboration aims to scale previous work in simulating EUV lithography, a critical process in next-generation semiconductor fabrication. This effort combines Canadian expertise in photonic quantum computing with Japanese materials science capabilities.

Technical Objectives

EUV lithography is essential for creating powerful chips used in mobile, AI, and advanced computing industries. However, its efficiency is often hindered by radiation-induced blurring, a quantum phenomenon that remains a bottleneck for classical simulations.

In phase one of the collaboration, Xanadu and Mitsubishi Chemical demonstrated that quantum algorithms could accurately model key aspects of EUV lithography, specifically the optical properties of photoresists used to etch lithographic patterns.

The next phase focuses on developing a production-ready workflow. This involves integrating parameters derived from Xanadu’s quantum computing simulations directly into Mitsubishi’s multi-scale models to predict blur. The goal is to create a fault-tolerant quantum computing (FTQC)-ready software pipeline designed to identify materials that prevent blurring.

Government Support

The second phase is supported by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) and Japan’s Strategic Innovation Promotion Program (SIP). The SIP project is led by the National Institute of Advanced Industrial Science and Technology (AIST) and the Global Research and Development Center for Business by Quantum-AI Technology (G-QuAT).

Xanadu has previously received advisory services and more than $800,000 in funding from NRC IRAP. This prior support helped lay the groundwork for the current advancement in quantum computing R&D.

Strategic Impact

Dr. Christian Weedbrook, Founder and Chief Executive Officer of Xanadu, stated that the collaboration bridges quantum simulation and semiconductor fabrication. He noted that the government funding underscores the partnership’s importance to advancing the global semiconductor industry.

Dr. Qi Gao, Senior Chief Scientist at Mitsubishi Chemical, highlighted that the partnership expands on previous successful work demonstrating the utility of quantum computing in simulating EUV resist materials.

Dr. Masahiro Horibe, Sub-Program Director at AIST, described the project as an example of connecting cutting-edge quantum research with real industrial challenges. He expressed expectation that the Japan-Canada collaboration will accelerate the real-world implementation of quantum technology.

Xanadu Quantum Technologies Limited (TSX: XNDU) and the University of Alberta announced a strategic research partnership to pioneer novel quantum algorithms for cancer treatment. The collaboration aims to develop a quantum computing framework that accelerates the design of next-generation photosensitizers used in photodynamic therapy, a non-invasive therapeutic approach.

Partnership Scope

The initiative is led by Xanadu’s algorithms team and Professor Alex Brown from the University of Alberta. The partnership seeks to overcome classical computational challenges in photodynamic drug discovery by modeling critical light-matter interactions within photosensitizers. These interactions determine key properties such as sensitivity to specific wavelengths and efficiency in triggering cancer cell death, which are difficult to predict using standard methods.

Photodynamic therapy uses light-activated compounds to selectively destroy tumor cells while avoiding side effects associated with traditional chemotherapy. However, discovering effective photosensitizers requires either slow, costly experiments or classical simulations that fail to capture crucial excited-state processes accurately.

Strategic Context

Xanadu recently released results demonstrating the use of quantum computers to simulate light-matter interactions in photosensitizers. Professor Brown has published influential work on benchmarking computational simulations of these systems. By combining their expertise, the partners aim to explore how early fault-tolerant quantum computers can provide new tools for understanding and designing more effective light-activated cancer treatments.

"Current methodologies for developing effective photosensitizers are hampered by a variety of hurdles," said Dr. Christian Weedbrook, Founder and Chief Executive Officer of Xanadu. "By leveraging early fault-tolerant quantum computers to model critical light-matter interactions within photosensitizers, we are positioning quantum computing as a highly competitive method for accelerating photodynamic drug discovery."

Professor Brown added, "Photosensitizers are challenging systems because their performance depends on excited-state processes that are difficult to capture accurately with standard computational methods. By combining Xanadu’s quantum algorithm expertise with our experience in modeling photodynamic therapy systems, we’re excited to explore how fault-tolerant quantum computing could provide new tools for understanding and designing more effective light-activated cancer treatments."

What the Numbers Show

Xanadu reported raising more than $600 million USD in funding to support its development of fault-tolerant quantum computers using light. This capital base supports the company’s dual focus on hardware and software, including its open-source platform PennyLane, as it expands its quantum-based workflow for drug design.

Company Profile

Founded in 2016, Xanadu is a Canadian photonic quantum computing company listed on Nasdaq and the Toronto Stock Exchange (TSX: XNDU). It is the first pure-play photonic quantum computing company to list on public markets. The University of Alberta ranks among the top four universities in Canada and generates an annual economic impact of $19.4 billion in Alberta alone.